What is Bausch + Lomb Corporation's earnings per share (EPS)?

Bausch + Lomb Corporation (BLCO) reported diluted earnings per share of -$1.02 for fiscal year 2025. This represents a -13.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Bausch + Lomb Corporation (BLCO) Financials

BLCO

Trailing 12 months to June 30, 2026

Revenue $5.3B +8.9% YoY

Net Income -$171.0M +37.4% YoY

EPS (Diluted) -$0.49 +37.2% YoY

Free Cash Flow $137.0M +183.0% YoY

Market Cap $6.1B as of Oct 3, 2026

Price / Sales 1.1x on $5.3B revenue, trailing 12 months to June 30, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026

Price / Book 1.0x on $6.4B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 29, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 29, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BLCO SEC filings page.

Bausch + Lomb Corporation (BLCO) reported $5.3B in revenue over the twelve months to Jun 30, 2026, up 8.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BLCO FY2025 2026-10-03

Bausch + Lomb is growing sales, but rising operating costs, interest and reinvestment keep earnings negative.

Across the reported period, revenue increased 35.5% while operating margin fell 6.5% percentage points; sales expansion produced less operating profit per dollar. In FY2025, positive operating cash flow of $283M still became free cash flow of -$66M, showing that reinvestment absorbed more cash than operations produced.

Debt rose from $0 to $5.02B across the reported periods, materially changing the financing structure. In FY2025, interest expense of $421M exceeded operating income of $113M, so financing costs prevented operating performance from reaching net income.

In FY2025, selling, general and administrative expense was $2.23B and research and development was $371M. Together, those costs sit alongside only $113M of operating income, indicating limited conversion of the sales base into operating profit.

Financial Health Signals

Financial Health Score 37/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Bausch + Lomb Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Bausch + Lomb Corporation has an operating margin of 2.2%, meaning the company retains $2 of operating profit per $100 of revenue. This results in a moderate score of 45/100, indicating healthy but not exceptional operating efficiency. This is down from 3.4% the prior year.

Growth

Bausch + Lomb Corporation's revenue grew 6.5% year-over-year to $5.1B, a solid pace of expansion. This earns a growth score of 67/100.

Leverage

Bausch + Lomb Corporation has elevated debt relative to equity (D/E of 0.78), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 6/100, reflecting increased financial risk.

Liquidity

Bausch + Lomb Corporation's current ratio of 1.55 indicates adequate short-term liquidity, earning a score of 43/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

While Bausch + Lomb Corporation generated $283.0M in operating cash flow, capex of $349.0M consumed most of it, leaving -$66.0M in free cash flow. This results in a low score of 21/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Bausch + Lomb Corporation posts a -5.6% return on equity (ROE), meaning it loses $6 for every $100 of shareholders' equity. This results in a returns score of 41/100. This is down from -4.9% the prior year.

Altman Z-Score Distress

0.88

Bausch + Lomb Corporation scores 0.88, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($6.1B) relative to total liabilities ($7.5B). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

3/8

Bausch + Lomb Corporation passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Mixed

N/A

Bausch + Lomb Corporation reported a net loss of $360.0M while generating $283.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk

0.27x

Bausch + Lomb Corporation earns $0.27 in operating income for every $1 of interest expense ($113.0M vs $421.0M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.4B

YoY+9.1%

QoQ+12.1%

5Y CAGR+8.3%

Bausch + Lomb Corporation generated $1.4B in revenue in Q2 2026. This represents an increase of 9.1% from the same quarter a year earlier. Against the prior quarter it is up 12.1%.

EBITDA

$185.0M

YoY+92.7%

QoQ+38.1%

5Y CAGR+1.8%

Bausch + Lomb Corporation's EBITDA was $185.0M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 92.7% from the same quarter a year earlier. Against the prior quarter it is up 38.1%.

Net Income

-$14.0M

YoY+77.4%

QoQ+80.3%

Bausch + Lomb Corporation reported -$14.0M in net income in Q2 2026. This represents an increase of 77.4% from the same quarter a year earlier. Against the prior quarter it is up 80.3%.

EPS (Diluted)

-$0.04

YoY+77.8%

QoQ+80.0%

Bausch + Lomb Corporation earned -$0.04 per diluted share (EPS) in Q2 2026. This represents an increase of 77.8% from the same quarter a year earlier. Against the prior quarter it is up 80.0%.

Cash & Balance Sheet

Free Cash Flow

$82.0M

YoY+251.9%

QoQ+220.6%

5Y CAGR-16.7%

Bausch + Lomb Corporation generated $82.0M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 251.9% from the same quarter a year earlier. Against the prior quarter it is up 220.6%.

Cash & Debt

$367.0M

YoY+38.0%

QoQ+36.9%

5Y CAGR+5.5%

Bausch + Lomb Corporation held $367.0M in cash against $5.0B in long-term debt as of Q2 2026.

Shares Outstanding

357M

YoY+0.9%

QoQ+0.2%

Bausch + Lomb Corporation had 357M shares outstanding in Q2 2026. This represents an increase of 0.9% from the same quarter a year earlier. Against the prior quarter it is up 0.2%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Operating Margin

5.9%

YoY+6.8pp

QoQ+3.3pp

5Y change-0.3pp

Bausch + Lomb Corporation's operating margin was 5.9% in Q2 2026, reflecting core business profitability. This is up 6.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.3 percentage points.

Net Margin

-1.0%

YoY+3.9pp

QoQ+4.7pp

5Y change-5.7pp

Bausch + Lomb Corporation's net profit margin was -1.0% in Q2 2026, showing the share of revenue converted to profit. This is up 3.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.7 percentage points.

Return on Equity

-0.2%

YoY+0.7pp

QoQ+0.9pp

5Y change-0.7pp

Bausch + Lomb Corporation's ROE was -0.2% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.9 percentage points.

Gross Margin

Not reported for Q2 2026.

Capital Allocation

R&D Spending

$114.0M

YoY+18.8%

QoQ+12.9%

5Y CAGR+9.9%

Bausch + Lomb Corporation invested $114.0M in research and development in Q2 2026. This represents an increase of 18.8% from the same quarter a year earlier. Against the prior quarter it is up 12.9%.

Capital Expenditures

$71.0M

YoY-20.2%

QoQ-29.0%

5Y CAGR+9.5%

Bausch + Lomb Corporation invested $71.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 20.2% from the same quarter a year earlier. Against the prior quarter it is down 29.0%.

Share Buybacks

Not reported for Q2 2026.

BLCO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BLCO quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Revenue	$5.3B	$5.1B+6.5%	$4.8B+15.6%	$4.1B+10.0%	$3.8B+0.1%	$3.8B+10.3%	$3.4B
R&D Expenses	$404.0M	$371.0M+8.2%	$343.0M+5.9%	$324.0M+5.5%	$307.0M+13.3%	$271.0M+7.1%	$253.0M
SG&A Expenses	$2.2B	$2.2B+7.3%	$2.1B+19.9%	$1.7B+17.5%	$1.5B+6.4%	$1.4B+10.9%	$1.3B
Operating Income	$323.0M	$113.0M-30.2%	$162.0M+24.6%	$130.0M-37.2%	$207.0M-37.1%	$329.0M+26.5%	$260.0M
EBITDA	N/A	$534.0M-10.7%	$598.0M+16.8%	$512.0M-12.6%	$586.0M-21.2%	$744.0M+6.0%	$702.0M
Interest Expense	$389.0M	$421.0M+5.5%	$399.0M+41.0%	$283.0M+93.8%	$146.0M	$0	$0
Income Tax	$98.0M	$35.0M-50.7%	$71.0M-13.4%	$82.0M+41.4%	$58.0M-53.6%	$125.0M-59.3%	$307.0M
Net Income	-$171.0M	-$360.0M-13.6%	-$317.0M-21.9%	-$260.0M-4433.3%	$6.0M-96.7%	$182.0M+1111.1%	-$18.0M
EPS (Basic)	N/A	-$1.02-13.3%	-$0.90-21.6%	-$0.74-3800.0%	$0.02-96.2%	$0.52+1140.0%	-$0.05
EPS (Diluted)	-$0.49	-$1.02-13.3%	-$0.90-21.6%	-$0.74-3800.0%	$0.02-96.2%	$0.52+1140.0%	-$0.05
Diluted Shares (Avg)	N/A	354M+0.6%	352M+0.4%	351M+0.1%	350M+0.1%	350M0.0%	350M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$1.4B+9.1%	$1.2B+9.4%	$1.4B+9.8%	$1.3B+7.1%	$1.3B+5.1%	$1.1B+3.5%	$1.3B+9.1%	$1.2B+18.8%
R&D Expenses	$114.0M+18.8%	$101.0M+17.4%	$94.0M+1.1%	$95.0M+13.1%	$96.0M+14.3%	$86.0M+4.9%	$93.0M+16.3%	$84.0M+2.4%
SG&A Expenses	$588.0M+1.6%	$544.0M-3.4%	$564.0M+6.0%	$528.0M+3.3%	$579.0M+8.2%	$563.0M+11.7%	$532.0M+10.1%	$511.0M+22.2%
Operating Income	$83.0M+854.5%	$33.0M+139.8%	$112.0M+28.7%	$95.0M+120.9%	-$11.0M-142.3%	-$83.0M-1483.3%	$87.0M+77.6%	$43.0M+7.5%
EBITDA	$185.0M+92.7%	$134.0M+482.6%	$211.0M+9.3%	$204.0M+33.3%	$96.0M-29.4%	$23.0M-80.2%	$193.0M+17.0%	$153.0M+25.4%
Interest Expense	$93.0M-27.3%	$97.0M+3.2%	$98.0M0.0%	$101.0M+1.0%	$128.0M+25.5%	$94.0M-5.1%	$98.0M-1.0%	$100.0M+31.6%
Income Tax	-$1.0M+98.9%	$6.0M-80.6%	$71.0M+987.5%	$22.0M+133.3%	-$89.0M-223.6%	$31.0M-57.5%	-$8.0M-33.3%	-$66.0M-246.7%
Net Income	-$14.0M+77.4%	-$71.0M+66.5%	-$58.0M-1833.3%	-$28.0M-800.0%	-$62.0M+58.9%	-$212.0M-26.9%	-$3.0M+94.4%	$4.0M+104.8%
EPS (Basic)	-$0.04+77.8%	-$0.20+66.7%	-$0.17-1600.0%	-$0.08-900.0%	-$0.18+58.1%	-$0.60-25.0%	-$0.01+93.3%	$0.01+104.2%
EPS (Diluted)	-$0.04+77.8%	-$0.20+66.7%	-$0.17-1600.0%	-$0.08-900.0%	-$0.18+58.1%	-$0.60-25.0%	-$0.01+93.3%	$0.01+104.2%
Diluted Shares (Avg)	357M+1.0%	355M+0.7%	N/A	354M+0.1%	354M+0.5%	353M+0.5%	N/A	354M+0.9%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit.

BLCO Balance Sheet

BLCO quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Total Assets	$14.0B+4.1%	$13.5B+0.2%	$13.4B+20.6%	$11.1B+3.0%	$10.8B	N/A
Current Assets	$3.0B+6.8%	$2.8B+1.7%	$2.7B+28.3%	$2.1B+30.7%	$1.6B	N/A
Cash & Equivalents	$383.0M+25.6%	$305.0M-7.9%	$331.0M-6.5%	$354.0M+103.4%	$174.0M-26.9%	$238.0M
Short-Term Investments	$0	$0	$0	$0	$0	$0
Inventory	$976.0M-5.8%	$1.0B+0.8%	$1.0B+63.7%	$628.0M+9.8%	$572.0M	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0
Goodwill	$4.8B+5.2%	$4.5B-1.1%	$4.6B+1.5%	$4.5B-1.7%	$4.6B-2.1%	$4.7B
Total Liabilities	$7.5B+8.3%	$6.9B+6.2%	$6.5B+61.3%	$4.0B+184.5%	$1.4B	N/A
Current Liabilities	$1.9B+10.5%	$1.7B+10.1%	$1.6B+21.8%	$1.3B+17.9%	$1.1B	N/A
Non-Current Liabilities	$5.6B+7.6%	$5.2B+4.9%	$4.9B+79.9%	$2.7B+753.1%	$322.0M	N/A
Long-Term Debt	$5.0B+5.8%	$4.7B+4.7%	$4.5B+88.0%	$2.4B	$0	N/A
Total Equity	$6.4B-0.4%	$6.5B-5.5%	$6.8B-2.6%	$7.0B-24.6%	$9.3B-6.6%	$10.0B
Retained Earnings	-$931.0M-63.0%	-$571.0M-124.8%	-$254.0M-4333.3%	$6.0M	$0	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$13.9B+0.2%	$13.8B+2.6%	$14.0B+4.1%	$13.8B+2.3%	$13.8B+4.4%	$13.4B+1.0%	$13.5B+0.2%	$13.5B+3.4%
Current Assets	$2.9B+2.7%	$2.8B+3.0%	$3.0B+6.8%	$2.9B+1.0%	$2.8B+2.8%	$2.7B-1.8%	$2.8B+1.7%	$2.8B+14.8%
Cash & Equivalents	$367.0M+38.0%	$268.0M+32.7%	$383.0M+25.6%	$310.0M-5.8%	$266.0M-6.7%	$202.0M-35.9%	$305.0M-7.9%	$329.0M-7.3%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$999.0M-4.9%	$977.0M-5.2%	$976.0M-5.8%	$1.0B-10.2%	$1.1B-1.7%	$1.0B-3.9%	$1.0B+0.8%	$1.1B+48.4%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$4.7B+1.2%	$4.7B+3.7%	$4.8B+5.2%	$4.7B+1.7%	$4.7B+2.8%	$4.6B+0.4%	$4.5B-1.1%	$4.6B+1.2%
Total Liabilities	$7.4B+1.2%	$7.3B+4.8%	$7.5B+8.3%	$7.3B+7.0%	$7.3B+9.8%	$7.0B+6.6%	$6.9B+6.2%	$6.9B+10.8%
Current Liabilities	$1.9B+2.7%	$1.8B+5.4%	$1.9B+10.5%	$1.9B+5.3%	$1.8B+9.8%	$1.7B+6.7%	$1.7B+10.1%	$1.8B+29.9%
Non-Current Liabilities	$5.5B+0.7%	$5.5B+4.5%	$5.6B+7.6%	$5.4B+7.6%	$5.5B+9.8%	$5.3B+6.5%	$5.2B+4.9%	$5.1B+5.3%
Long-Term Debt	$5.0B+2.4%	$5.0B+4.6%	$5.0B+5.8%	$4.9B+7.0%	$4.9B+7.1%	$4.8B+5.2%	$4.7B+4.7%	$4.6B+3.7%
Total Equity	$6.4B-1.0%	$6.4B+0.3%	$6.4B-0.4%	$6.4B-2.4%	$6.4B-1.0%	$6.4B-4.5%	$6.5B-5.5%	$6.6B-3.3%
Retained Earnings	-$1.0B-20.2%	-$1.0B-28.0%	-$931.0M-63.0%	-$873.0M-53.7%	-$845.0M-47.7%	-$783.0M-86.0%	-$571.0M-124.8%	-$568.0M-184.0%

Not reported in any period shown, so not listed: Accounts Receivable.

BLCO Cash Flow Statement

BLCO quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Operating Cash Flow	$458.0M	$283.0M+22.0%	$232.0M+1464.7%	-$17.0M-104.9%	$345.0M-60.5%	$873.0M+67.2%	$522.0M
Depreciation & Amortization	N/A	$421.0M-3.4%	$436.0M+14.1%	$382.0M+0.8%	$379.0M-8.7%	$415.0M-6.1%	$442.0M
Stock-Based Compensation	N/A	$149.0M+62.0%	$92.0M+24.3%	$74.0M+19.4%	$62.0M0.0%	$62.0M+24.0%	$50.0M
Capital Expenditures	$321.0M	$349.0M+19.9%	$291.0M+60.8%	$181.0M+3.4%	$175.0M-9.3%	$193.0M-23.7%	$253.0M
Free Cash Flow	$137.0M	-$66.0M-11.9%	-$59.0M+70.2%	-$198.0M-216.5%	$170.0M-75.0%	$680.0M+152.8%	$269.0M
Investing Cash Flow	-$466.0M	-$455.0M-10.4%	-$412.0M+80.5%	-$2.1B-880.9%	-$215.0M-0.5%	-$214.0M+16.4%	-$256.0M
Financing Cash Flow	$118.0M	$225.0M+26.4%	$178.0M-91.4%	$2.1B+2465.4%	$81.0M+111.4%	-$712.0M-206.9%	-$232.0M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$153.0M+337.1%	$32.0M+228.0%	$136.0M+518.2%	$137.0M-11.0%	$35.0M+133.3%	-$25.0M-161.0%	$22.0M+46.7%	$154.0M+220.8%
Depreciation & Amortization	$102.0M-4.7%	$101.0M-4.7%	$99.0M-6.6%	$109.0M-0.9%	$107.0M-2.7%	$106.0M-3.6%	$106.0M-8.6%	$110.0M+34.1%
Stock-Based Compensation	$38.0M+26.7%	$34.0M+21.4%	N/A	$27.0M+12.5%	$30.0M+36.4%	$28.0M+47.4%	N/A	$24.0M+50.0%
Capital Expenditures	$71.0M-20.2%	$100.0M-9.1%	$76.0M-17.4%	$74.0M+23.3%	$89.0M+23.6%	$110.0M+64.2%	$92.0M+9.5%	$60.0M+81.8%
Free Cash Flow	$82.0M+251.9%	-$68.0M+49.6%	$60.0M+185.7%	$63.0M-33.0%	-$54.0M+5.3%	-$135.0M-419.2%	-$70.0M-1.4%	$94.0M+526.7%
Investing Cash Flow	-$87.0M+3.3%	-$130.0M-12.1%	-$188.0M-1.6%	-$61.0M+36.5%	-$90.0M-21.6%	-$116.0M-103.5%	-$185.0M-37.0%	-$96.0M+94.9%
Financing Cash Flow	$34.0M-62.2%	-$20.0M-164.5%	$116.0M-20.5%	-$12.0M+40.0%	$90.0M+125.0%	$31.0M+158.3%	$146.0M+69.8%	-$20.0M-101.1%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

BLCO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BLCO quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Operating Margin	2.2%-1.2pp	3.4%+0.2pp	3.1%-2.4pp	5.5%-3.3pp	8.7%+1.1pp	7.6%
Net Margin	-7.1%-0.4pp	-6.6%-0.3pp	-6.3%-6.4pp	0.2%-4.7pp	4.8%+5.4pp	-0.5%
Return on Equity	-5.6%-0.7pp	-4.9%-1.1pp	-3.8%-3.9pp	0.1%-1.9pp	1.9%+2.1pp	-0.2%
Return on Assets	-2.6%-0.2pp	-2.4%-0.4pp	-1.9%-2.0pp	0.1%-1.6pp	1.7%	N/A
Current Ratio	1.55-0.1x	1.60-0.1x	1.74+0.1x	1.65+0.2x	1.49	N/A
Debt-to-Equity	0.780.0x	0.73+0.1x	0.66+0.3x	0.34+0.3x	0.00	N/A
Asset Turnover	0.360.0x	0.360.0x	0.310.0x	0.340.0x	0.35	N/A
FCF Margin	-1.3%-0.1pp	-1.2%+3.6pp	-4.8%-9.3pp	4.5%-13.6pp	18.1%+10.2pp	7.9%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Margin	5.9%+6.8pp	2.6%+9.9pp	8.0%+1.2pp	7.4%+3.8pp	-0.9%-3.0pp	-7.3%-7.8pp	6.8%+2.6pp	3.6%-0.4pp
Net Margin	-1.0%+3.9pp	-5.7%+12.9pp	-4.1%-3.9pp	-2.2%-2.5pp	-4.9%+7.6pp	-18.6%-3.5pp	-0.2%+4.4pp	0.3%+8.7pp
Return on Equity	-0.2%+0.7pp	-1.1%+2.2pp	-0.9%-0.9pp	-0.4%-0.5pp	-1.0%+1.4pp	-3.3%-0.8pp	0.0%+0.7pp	0.1%+1.3pp
Return on Assets	-0.1%+0.3pp	-0.5%+1.1pp	-0.4%-0.4pp	-0.2%-0.2pp	-0.4%+0.7pp	-1.6%-0.3pp	0.0%+0.4pp	0.0%+0.7pp
Current Ratio	1.550.0x	1.530.0x	1.55-0.1x	1.51-0.1x	1.55-0.1x	1.56-0.1x	1.60-0.1x	1.57-0.2x
Debt-to-Equity	0.790.0x	0.790.0x	0.780.0x	0.77+0.1x	0.77+0.1x	0.75+0.1x	0.73+0.1x	0.700.0x
Asset Turnover	0.100.0x	0.090.0x	0.100.0x	0.090.0x	0.090.0x	0.080.0x	0.100.0x	0.090.0x
FCF Margin	5.9%+10.1pp	-5.5%+6.4pp	4.3%+9.7pp	4.9%-2.9pp	-4.2%+0.5pp	-11.9%-9.5pp	-5.5%+0.4pp	7.9%+6.4pp

Not reported in any period shown, so not listed: Gross Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Bausch + Lomb Corporation BLCO	FY2025	$5.1B	-$360.0M	-7.1%	$6.1B	37/100
Teleflex Incorporated TFX	FY2025	$2.0B	-$905.6M	-45.5%	$5.3B	48/100
Merit Medical Systems Inc MMSI	FY2025	$1.5B	$128.5M	8.5%	$5.1B	69/100
Repligen Corp RGEN	FY2025	$738.3M	$48.9M	6.6%	$10.3B	68/100
Envista Holdings Corporation NVST	FY2025	$2.7B	$47.0M	1.7%	$3.8B	43/100

Where Bausch + Lomb Corporation Ranks

Frequently Asked Questions

What is Bausch + Lomb Corporation's annual revenue?

Bausch + Lomb Corporation (BLCO) reported $5.1B in total revenue for fiscal year 2025. This represents a 6.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Bausch + Lomb Corporation's revenue growing?

Bausch + Lomb Corporation (BLCO) revenue grew by 6.5% year-over-year, from $4.8B to $5.1B in fiscal year 2025.

Is Bausch + Lomb Corporation profitable?

No, Bausch + Lomb Corporation (BLCO) reported a net income of -$360.0M in fiscal year 2025, with a net profit margin of -7.1%.

What is Bausch + Lomb Corporation's EBITDA?

Bausch + Lomb Corporation (BLCO) had EBITDA of $534.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Bausch + Lomb Corporation have?

As of fiscal year 2025, Bausch + Lomb Corporation (BLCO) had $383.0M in cash and equivalents against $5.0B in long-term debt.

What is Bausch + Lomb Corporation's operating margin?

Bausch + Lomb Corporation (BLCO) had an operating margin of 2.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Bausch + Lomb Corporation's net profit margin?

Bausch + Lomb Corporation (BLCO) had a net profit margin of -7.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Bausch + Lomb Corporation's return on equity (ROE)?

Bausch + Lomb Corporation (BLCO) has a return on equity of -5.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Bausch + Lomb Corporation's free cash flow?

Bausch + Lomb Corporation (BLCO) recorded an outflow of $66.0M in free cash flow during fiscal year 2025. This represents a -11.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Bausch + Lomb Corporation's operating cash flow?

Bausch + Lomb Corporation (BLCO) generated $283.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Bausch + Lomb Corporation's total assets?

Bausch + Lomb Corporation (BLCO) had $14.0B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Bausch + Lomb Corporation's capital expenditures?

Bausch + Lomb Corporation (BLCO) invested $349.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Bausch + Lomb Corporation spend on research and development?

Bausch + Lomb Corporation (BLCO) invested $371.0M in research and development during fiscal year 2025.

How many shares does Bausch + Lomb Corporation have outstanding?

Bausch + Lomb Corporation (BLCO) had 354M shares outstanding as of fiscal year 2025.

What is Bausch + Lomb Corporation's current ratio?

Bausch + Lomb Corporation (BLCO) had a current ratio of 1.55 as of fiscal year 2025, which is generally considered healthy.

What is Bausch + Lomb Corporation's debt-to-equity ratio?

Bausch + Lomb Corporation (BLCO) had a debt-to-equity ratio of 0.78 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Bausch + Lomb Corporation's return on assets (ROA)?

Bausch + Lomb Corporation (BLCO) had a return on assets of -2.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Bausch + Lomb Corporation's P/E ratio?

Bausch + Lomb Corporation (BLCO) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $6.1B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Bausch + Lomb Corporation's price-to-sales ratio?

Bausch + Lomb Corporation (BLCO) trades at 1.1x sales, its market capitalization divided by revenue of $5.3B revenue, trailing 12 months to June 30, 2026. The market capitalization is $6.1B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Bausch + Lomb Corporation's Altman Z-Score?

Bausch + Lomb Corporation (BLCO) has an Altman Z-Score of 0.88, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Bausch + Lomb Corporation's Piotroski F-Score?

Bausch + Lomb Corporation (BLCO) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Bausch + Lomb Corporation's earnings high quality?

Bausch + Lomb Corporation (BLCO) reported a net loss of $360.0M while generating $283.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Bausch + Lomb Corporation cover its interest payments?

Bausch + Lomb Corporation (BLCO) has an interest coverage ratio of 0.27x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Bausch + Lomb Corporation?

Bausch + Lomb Corporation (BLCO) scores 37 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.